Mechanisms regulating resistance to inhibitors of topoisomerase II. - Wikidata - awgldk - TriplyDB

Mechanisms regulating resistance to inhibitors of topoisomerase II.

Mechanisms regulating resistance to inhibitors of topoisomerase II.

http://www.wikidata.org/entity/Q34361770

about

Topoisomerase IIα in chromosome instability and personalized cancer therapy.Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition.Regulation of multidrug resistance by microRNAs in anti-cancer therapy Topoisomerases: Resistance versus Sensitivity, How Far We Can Go?The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance.Nonstructural 5A impairs DNA damage repair: Implication of hepatitis C virus-mediated hepatocarcinogenesis.

P2860

Q35498796-9C3D3998-B9F9-477A-BA74-A53619517148 Q35832271-182813AB-89FD-42F9-B013-161BF58B1A2E Q37587311-24EB779B-73C2-4B2D-B30F-8824FE61A917 Q38968355-488F6852-9EBB-4F34-8731-044C326075B1 Q41890373-F7A545F2-8416-4FC8-A519-8457004E6058 Q49594024-00DD9409-84E7-422F-8C00-92B4ADD7C7EF Q52347275-1F41C863-CDDB-4927-9E8B-C3F203C1FD0D

P2860

Mechanisms regulating resistance to inhibitors of topoisomerase II.

http://www.wikidata.org/entity/Q34361770

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@ast

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@en

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@nl

type

label

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@ast

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@en

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@nl

prefLabel

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@ast

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@en

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@nl

P1433

Q34361770-E1BB66BC-D501-4418-BB7B-C0D1CEFC0FB6

P1476

Q34361770-DA7EF6BB-4C77-471D-9454-14167750BBD5

P2093

Q34361770-0E0E01A6-3BBF-4330-9257-FAA08F571D18

Q34361770-6E8B62FC-3BDA-4610-BC57-A0B76F3A8EAB

P2860

Q34361770-015AE921-D5DA-4E16-A2C5-6350C1A39AA0

Q34361770-01CA8CB2-1EF7-474E-9373-A8E652F12866

Q34361770-02B5DF53-BF7D-447E-B7CC-C386F5525CCB

Q34361770-042B1833-3297-4384-81D3-D1FCF1CB3435

Q34361770-04C79551-BEBB-4675-95D9-35F6869D450E

Q34361770-0671B104-F9B6-4DB1-A160-5DAD011F2B81

Q34361770-0B7A2B68-3C62-4232-826E-B1474D85B2CF

Q34361770-0DAB8730-6849-4E7F-9166-1CCA1C540BE1

Q34361770-0F3040B4-FFA7-440B-B3CC-46AE8B2489E5

Q34361770-157967B7-1F2D-4EEA-9E62-BC44D3BEA221

P304

Q34361770-618965C0-53D5-45D6-9876-377C171E6B1E

P31

Q34361770-566318E9-DB50-4BE0-9C73-89ADF5C743AC

P356

Q34361770-2853ABD9-4E3B-4435-AE22-ED72D8FE1FA4

P478

Q34361770-4C60D62D-A3AC-4980-9DBA-6CB203014F30

P577

Q34361770-1D90BD4F-42E8-400F-86B1-C55DC1CE24ED

P5875

Q34361770-EFCE1B78-1FE6-4B9D-9837-7CD2E1D4F64E

P698

Q34361770-3978EA5D-DE1B-4FF5-87A1-85A45E104FCF

P932

Q34361770-A478B425-1F98-4E7C-BCDB-DF2B5217A14A

P356

FPHAR.2013.00089

P1433

Frontiers in Pharmacology

P1476

Mechanisms regulating resistance to inhibitors of topoisomerase II.

@en

P2093

Mahrukh K Ganapathi

http://www.w3.org/2001/XMLSchema#string

Ram N Ganapathi

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and function of type II DNA topoisomerases

Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes

Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells

Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II

Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity.

Roles of NF-kappaB and 26 S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma.

Casein kinase II phosphorylates the eukaryote-specific C-terminal domain of topoisomerase II in vivo.

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.

Adriamycin-a review.

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

P304

89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2013.00089

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255179139

http://www.w3.org/2001/XMLSchema#string

P698

23914174

http://www.w3.org/2001/XMLSchema#string

P932

3729981

http://www.w3.org/2001/XMLSchema#string